Biovilol Carvedilol 6.25mg
Biovilol (carvedilol 6.25mg) is a twice-daily tablet with a uniquely broad mechanism — it blocks both beta receptors in the heart and alpha-1 receptors in blood vessel walls simultaneously. This dual blockade slows the heart, reduces its workload, and widens blood vessels at the same time, making carvedilol one of the most powerful and versatile cardiovascular medicines available. It is one of only three beta-blockers in the world with robust clinical evidence for reducing mortality in chronic heart failure.
Brand name : Biovilol
Active ingredient : Carvedilol 6.25mg
Drug class : Alpha + Beta blocker
Requires prescription : Yes
What makes carvedilol unique — the dual-action difference
Most beta-blockers only block beta receptors in the heart. Carvedilol goes further — it simultaneously blocks alpha-1 receptors in blood vessel walls, causing them to relax and widen. This gives carvedilol a two-pronged cardiovascular effect that standard beta-blockers cannot match.
Beta blockade (heart)
Beta-1 and beta-2 receptors
Slows heart rate, reduces the force of each heartbeat, lowers cardiac output, and suppresses adrenaline-driven stress on the heart muscle.
Alpha-1 blockade (vessels)
Peripheral blood vessel walls
Relaxes and widens blood vessels, reducing the resistance the heart has to pump against — lowering blood pressure and easing the overall workload on a weakened heart.
Slower heart rate
Lower blood pressure
Wider blood vessels
Less cardiac strain
How does carvedilol compare to other beta-blockers?
| Atenolol | Metoprolol (ZOK) | Carvedilol (Biovilol) | |
|---|---|---|---|
| Beta blockade | Beta-1 only | Beta-1 only | Beta-1 + Beta-2 |
| Alpha-1 blockade | No | No | Yes |
| Vasodilation effect | No | No | Yes |
| Heart failure approved | No | Yes (ZOK only) | Yes |
| Antioxidant properties | No | No | Yes |
Carvedilol's additional alpha-1 blockade and antioxidant properties give it a broader cardiovascular protective effect — particularly valuable in heart failure and post-heart attack recovery where reducing vascular resistance and oxidative stress are critical treatment goals.
What is Biovilol carvedilol 6.25mg used for?
Chronic heart failure (CHF)
One of only three beta-blockers globally proven to reduce death rates in stable chronic heart failure. The 6.25mg dose is the standard starting dose — carefully titrated upward over weeks under specialist supervision. Carvedilol has been shown to reduce hospitalisation, improve symptoms, and significantly extend life in heart failure patients.
High blood pressure (hypertension)
The combined beta and alpha-1 blockade provides effective blood pressure reduction through two complementary mechanisms — slowing the heart and widening blood vessels simultaneously, making it a strong option for patients who need broader cardiovascular control.
Left ventricular dysfunction after a heart attack
Prescribed following a myocardial infarction where the heart's pumping ability has been impaired. Carvedilol helps the heart recover, reduces remodelling of damaged muscle tissue, and lowers the risk of subsequent cardiac events.
Stable angina (chest pain)
Reduces the frequency and severity of angina by decreasing the heart's oxygen demand and improving coronary blood flow, enabling greater physical activity with less discomfort.
Dosage & how to take
| Heart failure starting dose | 3.125mg twice daily for 2 weeks, then increased to 6.25mg twice daily |
| Heart failure target dose | Up to 25mg twice daily (titrated gradually under supervision) |
| Hypertension dose | 6.25mg twice daily, increasing to 12.5mg–25mg twice daily as needed |
| Post-heart attack dose | 6.25mg twice daily, titrated to 25mg twice daily |
| When to take | With food — taking with meals reduces the risk of dizziness from a rapid drop in blood pressure |
| Liver impairment | Use with caution — dose adjustment may be required |
| Missed dose | Take as soon as you remember; skip if nearly time for next dose. Never double up. |
Never stop carvedilol suddenly — abrupt withdrawal can trigger dangerous rebound hypertension or worsening heart failure. Always taper the dose gradually under medical supervision over 1 to 2 weeks.
Who should not take Biovilol carvedilol?
Key things to know before buying
Common side effects
Dizziness is most likely after the first dose or following a dose increase — taking the medicine with food significantly reduces this risk.
Most side effects are mild and settle within 1 to 2 weeks. Contact your doctor if dizziness is severe, your heart rate drops very low, or breathing becomes more difficult.